Sam Smith, PhD, discusses the relationship between menopausal symptoms and non-adherence in patients receiving tamoxifen.
Sam Smith, PhD, from University of Leeds, discusses the association between menopausal symptoms and adherence for patients with breast cancer taking tamoxifen.
This trial matched a patient’s adherence to the menopausal symptoms they experienced. Symptoms measured were headaches, nausea and vomiting, gynecologic issues, and hot flashes. Although no association was found between gynecologic symptoms or hot flashes and nonadherence, researchers did find that patients who experienced nausea and vomiting or headaches were less likely to adhere to their medication.